Wilson Sonsini Goodrich & Rosati's legacy closely traces the birth and evolution of Silicon Valley.
For nearly six decades, Wilson Sonsini has represented the technology pioneers associated with virtually every milestone innovation.
Today, the firm is synonymous with ushering promising, innovative companies through their business life cycle.
And as our clients have grown, so has our firm. Wilson Sonsini now represents many of the largest companies in the world—and thousands of the smallest ones, too.
On November 11, 2019, SunPower announced plans to separate into two independent, complementary, strategically-aligned and publicly-traded companies—SunPower and Maxeon Solar Technologies. Each company will focus on distinct offerings built on extensive experience across the solar value chain. Wilson Sonsini Goodrich & Rosati is advising SunPower in the transaction.
On October 28, 2019, Ascentage Pharma Group International (Ascentage Pharma), a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, hepatitis B virus, and age-related diseases, completed its initial public offering and listing on the Main Board of the Stock Exchange of Hong Kong, raising HK$416 million after issuing 12,180,900 shares at HK$34.20 per share, the high end of the price range. Its public offering tranche was more than 750 times over-subscribed, making it the most over-subscribed IPO stock in Hong Kong this year. Ascentage is the tenth pre-revenue biotech company listed on the Hong Kong Stock Exchange.
On October 22, 2019, The We Company (“WeWork”), a commercial real estate company, and SoftBank Group Corp., a prominent investor in technology companies, announced an agreement under which SoftBank will provide significant funding to WeWork.